Blood pressure variability predicts cognitive decline in Alzheimer's disease patients

Neurobiology of Aging

Volumn 35, Issue 10, 2014, Pages 2282-2287

  Lattanzi, Simona ^a   Luzzi, Simona ^a   Provinciali, Leandro ^a   Silvestrini, Mauro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Alzheimer's disease; Blood pressure; Blood pressure variability

Indexed keywords

DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COGNITIVE DEFECT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; DISEASE COURSE; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PRESSURE; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84903817434     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.04.023     Document Type: Article

References (42)

1. Akomolafe A., Beiser A., Meigs J.B., Au R., Green R.C., Farrer L.A., Wolf P.A., Seshadri S. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch. Neurol. 2006, 63:1551-1555.
2. Alpérovitch A., Blachier M., Soumaré A., Ritchie K., Dartigues J.F., Richard-Harston S., Tzourio C. Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study. Alzheimers Dement. 2013, [Epub ahead of print]. doi:10.1016/j.jalz.2013.05.1777.
3. Alrawi Y.A., Panerai R.B., Myint P.K., Potter J.F. Pharmacological blood pressure lowering in the older hypertensive patients may lead to cognitive impairment by altering neurovascular coupling. Med. Hypotheses 2013, 80:303-307.
4. Bellelli G., Frisoni G.B., Lucchi E., Guerini F., Geroldi C., Magnifico F., Bianchetti A., Trabucchi M. Lack of nighttime blood pressure reduction is associated with cognitive deterioration in subjects with long-standing hypertension. Blood Press. Monit. 2004, 9:71-76.
5. Breitner J.C., Wyse B.W., Anthony J.C., Welsh-Bohmer K.A., Steffens D.C., Norton M.C., Tschanz J.T., Plassman B.L., Meyer M.R., Skoog I., Khachaturian A. APOE epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 1999, 53:321-331.
6. Clark C.M., Sheppard L., Fillenbaum G.G., Galasko D., Morris J.C., Koss E., Mohs R., Heyman A. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Extablish a Registry for Alzheimer's Disease. Arch. Neurol. 1999, 56:857-862.
7. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002, 33:1152-1162.
8. de la Torre J.C. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc. Psychiatry Neurol. 2012, article ID 367516.
9. Fotuhi M., Hachinski V., Whitehouse P.J. Changing perspectives regarding late-life dementia. Nat. Rev. Neurol. 2009, 5:649-658.
10. Goldstein I.B., Bartzokis G., Guthrie D., Shapiro D. Ambulatory blood pressure and brain atrophy in the healthy elderly. Neurology 2002, 59:713-719.
11. Goldstein L.B., Bushnell C.D., Adams R.J., Appel L.J., Braun L.T., Chaturvedi S., Creager M.A., Culebras A., Eckel R.H., Hart R.G., Hinchey J.A., Howard V.J., Jauch E.C., Levine S.R., Meschia J.F., Moore W.S., Nixon J.V., Pearson T.A. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584. American Heart Association Stroke Council, Council on Cardiovascular NursingCouncil on Cardiovascular Nursing, Council on Epidemiology and PreventionCouncil on Epidemiology and Prevention, Council for High Blood Pressure ResearchCouncil for High Blood Pressure Research, Council on Peripheral Vascular DiseaseCouncil on Peripheral Vascular Disease, Interdisciplinary Council on Quality of Care and Outcomes ResearchInterdisciplinary Council on Quality of Care and Outcomes Research.
12. Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J.Appl. Physiol. 2006, 100:1059-1064.
13. Hofman A., Ott A., Breteler M.M., Bots M.L., Slooter A.J., van Harskamp F., van Duijn C.N., Van Broeckhoven C., Grobbee D.E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997, 349:151-154.
14. Honig L.S., Tang M.X., Albert S., Costa R., Luchsinger J., Manly J., Stern Y., Mayeux R. Stroke and the risk of Alzheimer disease. Arch. Neurol. 2003, 60:1707-1712.
15. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
16. Katsogridakis E., Bush G., Fan L., Birch A.A., Simpson D.M., Allen R., Potter J.F., Panerai R.B. Detection of impaired cerebral autoregulation improves by increasing arterial blood pressure variability. J.Cereb. Blood Flow Metab. 2013, 33:519-523.
17. Keary T.A., Gunstad J., Poppas A., Paul R.H., Jefferson A.L., Hoth K.F., Sweet L.H., Forman D.E., Cohen R.A. Blood pressure variability and dementia rating scale performance in older adults with cardiovascular disease. Cogn. Behav. Neurol. 2007, 20:73-77.
18. Kilander L., Nyman H., Boberg M., Hansson L., Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998, 31:780-786.
19. Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., Havlik R.J. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol. Aging 2000, 21:49-55.
20. Leys D., Kwiecinski H., Bogousslavsky J., Bath P., Brainin M., Diener H.C., Kaste M., Sivenius J., Hennerici M.G., Hacke W. Prevention. European stroke initiative. Cerebrovasc. Dis. 2004, 17(Suppl. 2):15-29. EUSI Executive Committee. EUSI Writing Committee.
21. Lopez O.L., Becker J.T., Saxton J., Sweet R.A., Klunk W., DeKosky S.T. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J. Am. Geriatr. Soc. 2005, 53:83-87.
22. Luzzi S., Vella L., Bartolini M., Provinciali L., Silvestrini M. Atherosclerosis in the evolution of Alzheimer's disease: can treatment reduce cognitive decline?. J.Alzheimers Dis. 2010, 20:893-901.
23. Manios E., Tsagalis G., Tsivgoulis G., Barlas G., Koroboki E., Michas F., Alexaki E., Vemmos K., Zakopoulos N.A. Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J.Hypertens. 2009, 27:2244-2248.
24. Manios E., Stamatelopoulos K., Tsivgoulis G., Barlas G., Koroboki E., Tsagalis G., Michas F., Vemmos K., Zakopoulos N.A. Time rate of blood pressure variation: a new factor associated with coronary atherosclerosis. J.Hypertens. 2011, 29:1109-1114.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
26. Mielke M.M., Zandi P.P., Sjögren M., Gustafson D., Ostling S., Steen B., Skoog I. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 2005, 64:1689-1695.
27. Ohya Y., Ohtsubo T., Tsuchihashi T., Eto K., Sadanaga T., Nagao T., Abe I., Fujishima M. Altered diurnal variation of blood pressure in elderly subjects with decreased activity of daily living and impaired cognitive functions. Hypertens. Res. 2001, 24:655-661.
28. Okonkwo O.C., Cohen R.A., Gunstad J., Poppas A. Cardiac output, blood pressure variability, and cognitive decline in geriatric cardiac patients. J.Cardiopulm. Rehabil. Prev. 2011, 31:290-297.
29. Ott A., Breteler M.M., de Bruyne M.C., van Harskamp F., Grobbee D.E., Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997, 28:316-321.
30. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999, 53:1937-1942.
31. Román G.C., Kalaria R.N. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol. Aging 2006, 27:1769-1785.
32. Rothwell P.M., Howard S.C., Dolan E., O'Brien E., Dobson J.E., Dahlöf B., Sever P.S., Poulter N.R. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010, 375:895-905.
33. Rothwell P.M. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010, 375:938-948.
34. Silvestrini M., Pasqualetti P., Baruffaldi R., Bartolini M., Handouk Y., Matteis M., Moffa F., Provinciali L., Vernieri F. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 2006, 37:1010-1015.
35. Silvestrini M., Gobbi B., Pasqualetti P., Bartolini M., Baruffaldi R., Lanciotti C., Cerqua R., Altamura C., Provinciali L., Vernieri F. Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. Neurobiol. Aging 2009, 30:1177-1183.
36. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., Persson G., Odén A., Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
37. Sperling R.A., Jack C.R., Black S.E., Frosch M.P., Greenberg S.M., Hyman B.T., Scheltens P., Carrillo M.C., Thies W., Bednar M.M., Black R.S., Brashear H.R., Grundman M., Siemers E.R., Feldman H.H., Schindler R.J. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011, 7:367-385.
38. Viticchi G., Falsetti L., Vernieri F., Altamura C., Bartolini M., Luzzi S., Provinciali L., Silvestrini M. Vascular predictors of cognitive decline in patients with mild cognitive impairment. Neurobiol. Aging 2012, 33:1127.
39. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjogren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., Scheltens P., European Task Force on Age-Related White Matter Changes Anew rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322.
40. Weimera D.L., Sager M.A. Early identification and treatment of Alzheimer's disease: social and fiscal outcomes. Alzheimers Dement. 2009, 5:215-226.
41. Zakopoulos N.A., Tsivgoulis G., Barlas G., Papamichael C., Spengos K., Manios E., Ikonomidis I., Kotsis V., Spiliopoulou I., Vemmos K., Mavrikakis M., Moulopoulos S.D. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005, 45:505-512.
42. Zakopoulos N.A., Tsivgoulis G., Barlas G., Spengos K., Manios E., Ikonomidis I., Toumanidis S., Dolianitis K., Vemmos K., Vassilopoulos D., Moulopoulos S.D. Impact of the time rate of blood pressure variation on left ventricular mass. J.Hypertens. 2006, 24:2071-2077.